Clinical trial
Alefacept in Patients With Severe Scalp Alopecia Areata
NCT00167102 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00167102 |
|---|---|
| Title | Alefacept in Patients With Severe Scalp Alopecia Areata |
| Official title | A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Alopecia Areata Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Alopecia Areata |
| Intervention type | Drug |
| Interventions | Alefacept |
| Enrollment | 45 |
| Start date | Jul 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 14, 2005 |
| Last update posted | May 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: